| Literature DB >> 35573880 |
Huixia Zhang1, Yan Li1, Zheng Li1, Christopher Wai-Kei Lam1, Peng Zhu1, Caiyun Wang1, Hua Zhou1, Wei Zhang1.
Abstract
Endogenous ribonucleotides (RNs) and deoxyribonucleotides (dRNs) are important metabolites related to the pathogenesis of many diseases. In light of their physiological and pathological significances, a novel and sensitive pre-column derivatization method with N-(t-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA) was developed to determine RNs and dRNs in human cells using high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS). A one-step extraction of cells with 85% methanol followed by a simple derivatization reaction within 5 min at room temperature contributed to shortened analysis time. The derivatives of 22 nucleoside mono-, di- and triphosphates were retained on the typical C18 column and eluted by ammonium acetate and acetonitrile in 9 min. Under these optimal conditions, good linearity was achieved in the tested calibration ranges. The lower limit of quantitation (LLOQ) was determined to be 0.1-0.4 μM for the tested RNs and 0.001-0.1 μM for dRNs. In addition, the precision (CV) was <15% and the RSD of stability was lower than 10.4%. Furthermore, this method was applied to quantify the endogenous nucleotides in human colorectal carcinoma cell lines HCT 116 exposed to 10-hydroxycamptothecin. In conclusion, our method has proven to be simple, rapid, sensitive, and reliable. It may be used for specific expanded studies on intracellular pharmacology in vitro.Entities:
Keywords: Deoxyribonucleotides; Derivatization; High-performance liquid chromatography tandem mass spectrometry; N-(t-butyldimethylsilyl)-N- methyltrifluoroacetamide; Ribonucleotides
Year: 2021 PMID: 35573880 PMCID: PMC9073140 DOI: 10.1016/j.jpha.2021.01.001
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Fig. 1(A) Full scan and (B) product ion mass spectra of silyl derivatives of the representative cytidine phosphates.
Fig. 2Effects of water content on nucleoside mono- (A), di- (B) and tri- (C) phosphates standard solutions.
Fig. 3Selected reconstructed MRM chromatograms of derivatives of (A) RNs and (B) dRNs using the established LC-MS/MS method.
Retention time, mass spectrometric parameters, and linear range or the quantification of each nucleotide derivative and internal standard in negative ion mode in the LC-MS/MS method.
| Analyte | Retention time (min) | Prototype [M − H]- | MTBSTFA derivative | ||||
|---|---|---|---|---|---|---|---|
| Precursor ion → Product ion ( | Tube lens (V) | Collision energy (eV) | Linear range (μM) | LLOQ (μM) | |||
| AMP | 8.23 | 346 | 460 → 134 | 157 | 26 | 0.2–20 | 0.2 |
| ADP | 5.78 | 426 | 540 → 328 | 129 | 15 | 0.2–20 | 0.2 |
| ATP | 4.37 | 506 | 620 → 408 | 116 | 18 | 0.4–40 | 0.4 |
| CMP | 7.77 | 322 | 436 → 110 | 176 | 17 | 0.2–20 | 0.2 |
| CDP | 5.37 | 402 | 516 → 304 | 95 | 18 | 0.2–20 | 0.2 |
| CTP | 3.94 | 482 | 596 → 384 | 99 | 20 | 0.4–40 | 0.4 |
| GMP | 7.46 | 362 | 476 → 150 | 176 | 27 | 0.1–10 | 0.1 |
| GDP | 5.38 | 442 | 556 → 344 | 130 | 16 | 0.2–20 | 0.2 |
| GTP | 4.29 | 522 | 636 → 424 | 118 | 16 | 0.4–40 | 0.4 |
| UMP | 8.20 | 323 | 437 → 111 | 127 | 21 | 0.2–20 | 0.2 |
| UDP | 5.57 | 403 | 517 → 305 | 110 | 13 | 0.2–20 | 0.2 |
| UTP | 4.29 | 483 | 597 → 385 | 95 | 19 | 0.4–40 | 0.4 |
| dAMP | 8.33 | 330 | 444 → 134 | 150 | 33 | 0.004–0.4 | 0.004 |
| dADP | 5.96 | 410 | 524 → 273 | 141 | 21 | 0.1–10 | 0.1 |
| dATP | 4.38 | 490 | 604 → 273 | 132 | 21 | 0.02–2 | 0.02 |
| dCMP | 7.87 | 306 | 420 → 211 | 160 | 23 | 0.004–0.4 | 0.004 |
| dCDP | 5.52 | 386 | 500 → 273 | 134 | 22 | 0.1–10 | 0.1 |
| dCTP | 4.33 | 466 | 580 → 273 | 122 | 21 | 0.02–2 | 0.02 |
| dGMP | 7.55 | 346 | 460 → 150 | 109 | 20 | 0.001–0.1 | 0.001 |
| dTMP | 8.93 | 321 | 435 → 125 | 133 | 24 | 0.004–0.4 | 0.004 |
| dTDP | 6.01 | 401 | 515 → 273 | 150 | 22 | 0.1–10 | 0.1 |
| dTTP | 4.37 | 481 | 595 → 273 | 134 | 24 | 0.02–2 | 0.02 |
| IS-AMP | 8.20 | 361 | 475 → 144 | 214 | 33 | – | – |
| IS-ATP | 4.37 | 521 | 635 → 273 | 108 | 28 | – | – |
Intra- and inter-day precision, accuracy, stability and matrix effect of the developed method.
| Analyte | Added (μM) | Precision | Accuracy | Stability ( | Matrix effect ( | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Intra-day CV (%) | Inter-day CV (%) | Intra-day RE (%) | Inter-day RE (%) | Mean ± SD (%) | RSD (%) | Mean ± SD (%) | RE (%) | RSD (%) | ||
| AMP | 0.6 | 6.2 | 10.2 | 3.4 | 4.8 | 110.7 ± 2.5 | 2.2 | 104.9 ± 3.3 | 4.9 | 3.1 |
| 3.0 | 7.6 | 9.2 | 6.6 | 6.7 | 110.6 ± 1.7 | 1.5 | 109.5 ± 1.1 | 9.5 | 1.0 | |
| 15.0 | 4.2 | 6.3 | −1.6 | −2.8 | 99.4 ± 4.9 | 5.0 | 107.9 ± 2.8 | 7.9 | 2.6 | |
| ADP | 0.6 | 3.6 | 9.7 | −0.5 | −2.2 | 109.0 ± 3.3 | 3.1 | 112.4 ± 4.6 | 12.4 | 4.1 |
| 3.0 | 10.2 | 9.5 | −0.3 | −0.2 | 107.9 ± 2.8 | 2.6 | 95.4 ± 3.7 | −4.6 | 3.8 | |
| 15.0 | 10.3 | 8.4 | −1.8 | 0.7 | 105.5 ± 4.4 | 4.2 | 101.1 ± 8.7 | 1.1 | 8.6 | |
| ATP | 1.2 | 8.9 | 11.2 | 4.3 | 7.4 | 104.3 ± 4.9 | 4.7 | 100.9 ± 5.1 | 0.9 | 5.0 |
| 6.0 | 5.6 | 9.5 | 3.1 | 6.2 | 103.1 ± 2.6 | 2.5 | 104.8 ± 3.6 | 4.8 | 3.5 | |
| 30.0 | 4.3 | 4.7 | 0.9 | 0.6 | 100.9 ± 4.4 | 4.3 | 99.5 ± 4.9 | −0.5 | 4.9 | |
| GMP | 0.3 | 12.7 | 11.1 | −7.1 | 2.2 | 95.3 ± 7.2 | 7.6 | 106.6 ± 6.3 | 6.6 | 5.9 |
| 1.5 | 14.4 | 10.7 | −10.8 | 1.5 | 86.4 ± 1.9 | 2.2 | 104.3 ± 4.0 | 4.3 | 3.8 | |
| 7.5 | 6.2 | 9.0 | 0.1 | −2.1 | 96.0 ± 6.7 | 7.0 | 98.8 ± 2.0 | −1.2 | 2.1 | |
| GDP | 0.6 | 4.4 | 8.5 | 0.1 | −2.2 | 102.8 ± 4.8 | 4.6 | 98.9 ± 6.7 | −1.1 | 6.7 |
| 3.0 | 4.5 | 6.2 | −1.0 | −0.1 | 109.4 ± 1.3 | 1.2 | 95.0 ± 3.8 | −5.0 | 4.0 | |
| 15.0 | 4.1 | 6.5 | −0.5 | 0.8 | 94.9 ± 9.9 | 10.4 | 104.6 ± 9.7 | 4.6 | 9.2 | |
| GTP | 1.2 | 5.4 | 10.1 | 2.3 | −4.1 | 102.3 ± 3.2 | 3.1 | 107.9 ± 6.3 | 7.9 | 5.8 |
| 6.0 | 5.3 | 9.7 | −3.1 | −4.5 | 96.9 ± 2.1 | 2.2 | 96.0 ± 4.1 | −4.0 | 4.3 | |
| 30.0 | 4.5 | 5.7 | −0.4 | −0.5 | 99.6 ± 4.1 | 4.1 | 101.3 ± 2.3 | 1.3 | 2.2 | |
| CMP | 0.6 | 12.9 | 12.1 | 3.1 | 0.8 | 111.1 ± 1.4 | 1.2 | 96.6 ± 6.9 | −3.4 | 7.1 |
| 3.0 | 14.1 | 10.9 | 7.8 | 4.5 | 112.2 ± 1.5 | 1.3 | 107.9 ± 3.1 | 7.9 | 2.9 | |
| 15.0 | 3.2 | 11.6 | 1.0 | −5.3 | 104.3 ± 7.1 | 6.8 | 100.8 ± 2.3 | 0.8 | 2.2 | |
| CDP | 0.6 | 6.9 | 8.1 | −2.6 | −3.0 | 104.4 ± 7.0 | 6.7 | 108.5 ± 2.6 | 8.5 | 2.4 |
| 3.0 | 5.4 | 8.2 | 1.8 | 0.3 | 109.9 ± 2.4 | 2.2 | 91.4 ± 3.8 | −8.6 | 4.2 | |
| 15.0 | 3.8 | 9.2 | 0.1 | 1.6 | 92.6 ± 1.7 | 1.8 | 105.4 ± 9.4 | 5.4 | 8.9 | |
| CTP | 1.2 | 8.4 | 9.9 | 5.1 | 6.6 | 105.1 ± 3.5 | 3.3 | 102.0 ± 4.6 | 2.0 | 4.6 |
| 6.0 | 1.3 | 3.4 | −0.1 | 0.6 | 99.9 ± 1.2 | 1.2 | 101.0 ± 4.0 | 1.0 | 4.0 | |
| 30.0 | 5.9 | 7.1 | 2.9 | −2.0 | 102.9 ± 3.2 | 3.1 | 106.6 ± 1.0 | 6.6 | 0.9 | |
| UMP | 0.6 | 6.6 | 11.7 | 3.9 | 5.4 | 108.1 ± 2.3 | 2.1 | 102.2 ± 3.2 | 2.2 | 3.2 |
| 3.0 | 4.4 | 7.4 | 2.7 | 4.3 | 109.1 ± 1.6 | 1.4 | 110.3 ± 1.9 | 10.3 | 1.7 | |
| 15.0 | 5.1 | 8.0 | −3.3 | −4.6 | 99.6 ± 5.8 | 5.8 | 102.4 ± 1.8 | 2.4 | 1.8 | |
| UDP | 0.6 | 5.5 | 6.3 | 0.2 | 1.3 | 98.9 ± 2.4 | 2.4 | 91.1 ± 7.3 | −8.9 | 8.0 |
| 3.0 | 5.7 | 5.6 | 0.6 | −0.4 | 99.2 ± 1.4 | 1.4 | 110.0 ± 4.1 | 10.0 | 3.8 | |
| 15.0 | 7.8 | 7.0 | −1.2 | −1.1 | 100.6 ± 9.3 | 9.2 | 95.5 ± 4.4 | −4.5 | 4.7 | |
| UTP | 1.2 | 4.1 | 13.3 | −0.1 | −2.8 | 99.9 ± 4.0 | 4.0 | 104.8 ± 5.5 | 4.8 | 5.2 |
| 6.0 | 5.0 | 13.3 | 2.8 | −4.8 | 102.8 ± 2.3 | 2.2 | 105.4 ± 8.2 | 5.4 | 7.8 | |
| 30.0 | 4.9 | 11.6 | 3.7 | −4.0 | 103.7 ± 1.2 | 1.2 | 97.4 ± 1.9 | −2.6 | 2.0 | |
| dAMP | 0.012 | 11.8 | 12.6 | 4.7 | 4.5 | 112.0 ± 2.4 | 2.1 | 109.2 ± 10.3 | 9.2 | 9.5 |
| 0.06 | 4.7 | 10.0 | 2.3 | 5.5 | 112.0 ± 2.1 | 1.8 | 112.2 ± 2.9 | 12.2 | 2.6 | |
| 0.3 | 7.3 | 6.9 | −3.5 | −3.7 | 98.3 ± 4.8 | 4.9 | 104.0 ± 4.0 | 4.0 | 3.8 | |
| dADP | 0.3 | 8.0 | 10.4 | 3.8 | −3.3 | 107.8 ± 5.7 | 5.3 | 104.3 ± 3.3 | 4.3 | 3.2 |
| 1.5 | 10.6 | 8.8 | −5.4 | −2.0 | 110.7 ± 1.8 | 1.6 | 91.5 ± 4.3 | −8.5 | 4.7 | |
| 7.5 | 9.3 | 10.2 | 3.8 | 4.6 | 110.7 ± 4.0 | 3.6 | 99.0 ± 8.7 | −1.0 | 8.7 | |
| dATP | 0.12 | 7.7 | 11.5 | 5.3 | 1.6 | 93.4 ± 6.1 | 6.6 | 99.0 ± 1.5 | −1.0 | 1.5 |
| 0.6 | 10.0 | 12.3 | −4.5 | 4.4 | 103.3 ± 5.3 | 5.1 | 108.0 ± 5.9 | 8.0 | 5.5 | |
| 3.0 | 6.1 | 12.0 | −1.1 | 4.9 | 110.6 ± 3.7 | 3.4 | 107.4 ± 5.4 | 7.4 | 5.1 | |
| dGMP | 0.003 | 12.3 | 10.0 | 2.2 | 1.1 | 90.9 ± 5.1 | 5.6 | 107.5 ± 9.9 | 7.5 | 9.2 |
| 0.015 | 5.8 | 9.9 | −1.1 | 3.4 | 93.6 ± 2.6 | 2.8 | 104.8 ± 12.5 | 4.8 | 11.9 | |
| 0.075 | 9.8 | 12.4 | 4.8 | 7.0 | 97.8 ± 6.5 | 6.6 | 113.9 ± 1.6 | 13.9 | 1.4 | |
| dCMP | 0.012 | 9.1 | 11.7 | 3.3 | 6.4 | 108.7 ± 4.4 | 4.0 | 97.9 ± 8.6 | −2.1 | 8.8 |
| 0.06 | 9.2 | 11.5 | 1.7 | 4.7 | 107.0 ± 7.1 | 6.6 | 102.5 ± 9.0 | 2.5 | 8.7 | |
| 0.3 | 3.1 | 9.9 | −1.3 | 3.0 | 105.8 ± 5.0 | 4.7 | 96.1 ± 1.8 | −3.9 | 1.8 | |
| dCDP | 0.3 | 5.6 | 12.1 | 1.1 | −3.4 | 99.2 ± 7.6 | 7.7 | 102.8 ± 7.2 | 2.8 | 7.0 |
| 1.5 | 6.7 | 11.1 | 3.2 | 4.7 | 99.9 ± 1.1 | 1.1 | 101.4 ± 4.8 | 1.4 | 4.7 | |
| 7.5 | 7.8 | 9.0 | 3.9 | −0.1 | 102.1 ± 4.1 | 4.0 | 103.0 ± 9.9 | 3.0 | 9.6 | |
| dCTP | 0.12 | 5.7 | 10.3 | 3.1 | 2.2 | 103.1 ± 2.7 | 2.6 | 103.7 ± 0.6 | 3.7 | 0.5 |
| 0.6 | 6.6 | 8.8 | 2.1 | −1.7 | 102.1 ± 4.6 | 4.5 | 108.1 ± 7.6 | 8.1 | 7.1 | |
| 3.0 | 10.4 | 14.8 | −7.8 | −10.4 | 92.2 ± 2.3 | 2.5 | 103.6 ± 3.2 | 3.6 | 3.1 | |
| dTMP | 0.012 | 8.1 | 9.7 | 5.4 | 2.7 | 98.8 ± 6.9 | 7.0 | 105.7 ± 10.0 | 5.7 | 9.5 |
| 0.06 | 4.3 | 9.1 | −0.6 | 1.8 | 102.7 ± 1.9 | 1.9 | 111.6 ± 4.3 | 11.6 | 3.8 | |
| 0.3 | 12.4 | 14.4 | −9.4 | −7.2 | 88.4 ± 3.6 | 4.0 | 102.0 ± 3.7 | 2.0 | 3.6 | |
| dTDP | 0.3 | 8.3 | 6.4 | −4.0 | −1.4 | 100.3 ± 6.1 | 6.1 | 106.1 ± 3.2 | 6.1 | 3.0 |
| 1.5 | 4.5 | 8.5 | −0.2 | −2.0 | 101.6 ± 5.7 | 5.6 | 100.1 ± 6.3 | 0.1 | 6.3 | |
| 7.5 | 8.3 | 8.8 | 3.3 | 4.3 | 106.0 ± 2.2 | 2.0 | 98.8 ± 8.4 | −1.2 | 8.5 | |
| dTTP | 0.12 | 3.2 | 9.4 | −0.3 | 2.9 | 99.7 ± 2.9 | 2.9 | 106.2 ± 8.0 | 6.2 | 7.5 |
| 0.6 | 9.9 | 12.8 | −3.2 | −7.0 | 92.5 ± 2.2 | 2.4 | 104.8 ± 4.1 | 4.8 | 3.9 | |
| 3.0 | 12.3 | 13.6 | 9.4 | 11.2 | 109.4 ± 3.6 | 3.3 | 108.2 ± 4.5 | 8.2 | 4.1 | |
Note: CV, coefficients of variation; RE: relative error; SD: standard deviation; RSD: relative standard deviation.
Amounts of RNs and dRN pools in HCT 116 cells treated with different dosages of 10-hydroxycamptothecin (pmol/106 cells, n=3).
| Analyte | Control | 0.1 μM | 1.0 μM |
|---|---|---|---|
| AMP | 1174.4 ± 77.8 | 3134.9 ± 159.0∗∗ | 52.8 ± 2.7∗∗ |
| ADP | 3088.3 ± 107.4 | 7838.3 ± 348.9∗∗ | 710.2 ± 129.1∗∗ |
| ATP | 3937.3 ± 99.3 | 6728.8 ± 184.8∗∗ | 6855.5 ± 92.2∗∗ |
| GMP | 141.9 ± 17.4 | 266.3 ± 42.3∗∗ | 26.7 ± 1.3∗∗ |
| GDP | 233.2 ± 16.1 | 856.8 ± 70.7∗∗ | 54.5 ± 8.5∗∗ |
| GTP | 212.8 ± 22.7 | 621.3 ± 41.9∗∗ | 361.3 ± 6.5∗∗ |
| CMP | 214.8 ± 14.1 | 575.6 ± 19.8∗∗ | 140.7 ± 3.1∗∗ |
| CDP | 300.3 ± 23.7 | 864.2 ± 70.5∗∗ | 69.2 ± 3.8∗∗ |
| CTP | 230.4 ± 24.4 | 621.4 ± 84.3∗∗ | 624.0 ± 45.2∗∗ |
| UMP | 775.2 ± 12.4 | 1648.8 ± 66.1∗∗ | 118.9 ± 8.5∗∗ |
| UDP | 444.1 ± 25.7 | 1206.4 ± 66.1∗∗ | 134.6 ± 8.5∗∗ |
| UTP | 500.3 ± 23.4 | 950.0 ± 110.2∗∗ | 1671.2 ± 36.2∗∗ |
| dAMP | 0.4 ± 0.1 | 2.7 ± 0.1∗∗ | 0.3 ± 0.0∗ |
| dADP | 11.2 ± 0.9 | 36.3 ± 6.7∗∗ | UDL |
| dATP | 5.9 ± 2.5 | 26.6 ± 8.2∗∗ | 7.1 ± 2.1 |
| dGMP | 0.5 ± 0.0 | 1.4 ± 0.1∗∗ | 0.2 ± 0.0∗∗ |
| dCMP | 3.2 ± 0.4 | 29.0 ± 2.0∗∗ | 8.6 ± 0.2∗∗ |
| dCDP | 7.3 ± 1.8 | 35.3 ± 1.1∗∗ | UDL |
| dCTP | 8.1 ± 1.5 | 27.1 ± 2.9∗∗ | 13.2 ± 0.9∗∗ |
| dTMP | 1.5 ± 0.4 | 4.8 ± 0.6∗∗ | 0.3 ± 0.0∗∗ |
| dTDP | 67.3 ± 6.3 | 207.3 ± 13.4∗∗ | 10.7 ± 18.5∗∗ |
| dTTP | 33.1 ± 9.2 | 82.7 ± 3.9∗∗ | 65.9 ± 1.5∗∗ |
Note: The result is expressed as mean ± standard deviation (SD) (n=3); ∗P < 0.05, ∗∗P < 0.01, compared with control group; UDL under detected limit of assay.
Fig. 4The statistical analysis of cell cycle distribution in HCT 116 cells upon the exposure of 10-hydroxycamptothecin. ∗∗P < 0.01, compared with control group.